Veerhealth Care Q1 FY27 Results: Revenue Surges 456% to Rs 24 Crore, PAT Rises to Rs 1 Crore

Veerhealth Care Q1 FY27 results showed the standalone healthcare company posting Rs 24 crore revenue, up 455.73% from Rs 4 crore in Q1 FY26. This dramatic revenue surge reflects either significant new hospital or clinic capacity commissioning, new diagnostic service launches, or major institutional healthcare contracts.

The Veerhealth Care Q1 FY27 results showed gross profit swinging from Rs -0.31 crore to Rs 1 crore on the revenue surge — a complete reversal of healthcare service economics from loss-making to profitable. PAT growing to Rs 1 crore from Rs 0.24 crore confirms the commercial viability of the scaled-up healthcare operations.

Click Here – Get Free Investment Predictions

Veerhealth Care Q1 FY27 Financial Highlights

Metric	Q1 FY27 (Rs Crore)	Q1 FY26 (Rs Crore)	YoY Change
Revenue	24.00	4.00	+455.73%
Gross Profit	1.00	-0.31	+592.06%
Net Profit / PAT	1.00	0.24	+409.81%

Veerhealth Care Q1 FY27 Performance Analysis

Use the Univest Screener to track Veerhealth Care live financials and Q1 FY27 results

Veerhealth Care Q1 FY27 results represent a dramatic healthcare services scale-up — revenue scaling 5x alongside gross profit turning positive confirms the company has crossed the healthcare capacity utilisation threshold above which operations become profitable.

Gross profit swinging from Rs -0.31 crore to Rs 1 crore in Q1 FY27 results points to the classic healthcare economics of fixed capacity: once beds, equipment, and staff are in place, additional patient volumes generate strong incremental margins.

PAT at Rs 1 crore in Q1 FY27 results, growing from Rs 0.24 crore, is modest in absolute terms on Rs 24 crore revenue — a PAT margin of 4.2%. For a healthcare company still in ramp-up phase, this is an encouraging initial profitability signal.

India's healthcare sector — particularly secondary and tertiary hospital care — is growing rapidly driven by insurance penetration, population health awareness, and the government's Ayushman Bharat programme extending hospitalisation access.

Key Business Factors in Q1 FY27

Healthcare Capacity Utilisation

Revenue 5x growth reflects higher patient volumes crossing the utilisation threshold where fixed healthcare capacity becomes profitable.

Service Scale-Up

New hospital capacity, diagnostic services, or institutional contracts drove the dramatic Q1 FY27 revenue surge.

Initial Profitability

Gross profit turning positive confirms the business has reached viable operational scale in Q1 FY27 results.

Dividend Details

Veerhealth Care has not declared a dividend for Q1 FY27. Healthcare expansion requires reinvestment of earnings.

FY27 Outlook

The FY27 outlook is positive with India's healthcare demand growth. Sustaining the Rs 24 crore quarterly revenue run-rate and improving operational efficiency would deliver improving PAT margins through the year.

Key risks include patient footfall consistency, healthcare regulatory compliance, and the ability to manage healthcare delivery quality at scale.

Veerhealth Care Stock Performance

Download the Univest iOS App or Univest Android App to track Veerhealth Care share price live and stay updated on quarterly results.

Veerhealth Care shares traded at Rs 46.52 on August 13, 2026, up 6.40%, reflecting strong market enthusiasm for the dramatic Q1 FY27 results scale-up.

Key Risks

Revenue Sustainability

Rs 24 crore quarterly revenue needs to be confirmed as a stable run-rate, not a one-time exceptional quarter.

Healthcare Regulatory Risk

Healthcare services face NABH, state medical council, and insurance panel compliance requirements.

Clinical Quality Risk

Rapid scale-up in healthcare must maintain clinical quality standards — patient safety issues have severe reputational and regulatory consequences.

Conclusion

Veerhealth Care Q1 FY27 results show exceptional 456% revenue surge to Rs 24 crore and PAT growing to Rs 1 crore — a dramatic healthcare services scale-up crossing profitability thresholds.

Revenue sustainability and operational quality management are the key investment assessment points. Consult a SEBI-registered advisor.

Frequently Asked Questions on Veerhealth Care Q1 FY27 Results

When announced?

Ans. August 13, 2026, standalone.

Revenue?

Ans. Rs 24 crore, up 455.73% from Rs 4 crore.

PAT?

Ans. Rs 1 crore, up 409.81% from Rs 0.24 crore.

What drove the 456% revenue surge?

Ans. Significant new healthcare capacity commissioning or institutional contracts driving patient volumes above the profitability threshold.

Dividend?

Ans. No dividend for Q1 FY27.

Outlook?

Ans. Positive with India's healthcare demand. Revenue sustainability is the key monitor.

Investment?

Ans. Dramatic scale-up in healthcare. Assess revenue recurrence and clinical quality. Consult a SEBI-registered advisor.